In silico Prediction of Two New Conformations of Aβ42 Peptide and Possible Mechanism of Their Aggregation

Authors

  • Arpita Devi

Abstract

Alzheimer’s disease is one of the most studied neurodegenerative diseases. The cause for most cases of this disease is unknown. However, there are many hypotheses regarding the progression of this disease. One of the hypotheses is the amyloid hypothesis. Amyloid precursor protein present on chromosome 21 is cleaved by β and γ sectretases. The cleaved fragments of this protein, nearly 36–43 residues long aggregates and are deposited as plaque in the brain. These peptides are called amyloid beta (Aβ). One of the peptide is 42 residues long and is well studied. For long, researchers have been trying to understand the factor that triggers this aggregation as well as the structure of 42 residue long amyloid beta (Aβ42). Various reports suggest that Aβ42 can adopt different conformations such as S-shaped and U-shaped beta sheet structure. In this report, we have predicted an L-shaped alpha-helical structure of Aβ42 as well as a beta-turn-beta structure. We have also predicted that aggregation is sequential and monomers are added one after another. Structurally, these aggregates are highly ordered structures which are stable in aqueous environment as compared to the monomers. Thus, hydrophobic forces may be a factor for the aggregation of amyloid beta peptides.

 

Keywords: Amyloid beta, L-shaped alpha-helix, beta-turn-beta, docking, molecular dynamics simulation

Cite this Article

Arpita Devi. In silico Prediction of Two New Conformations of Aβ42 Peptide and Possible Mechanism of their Aggregation. Research & Reviews: Journal of Computational Biology 2019; 8(1): 1-7p

Downloads

Published

2019-05-27

Issue

Vol. 8 No. 1 (2019)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.